History
# Registration date Revision Id
2 2024-08-09, 1403/05/19 312116
1 2022-07-03, 1401/04/12 232145
Changes made to previous revision
  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents
  • Protocol summary

    Comparison the effect of Lactobacillus rhamnosus, Lactobacillus fermentum and Lactobacillus plantarum on anthropometric indices and circulating level of metabolic parameters, oxidative stress and inflammatory biomarkers in obese individuals
    The assessment of the effect of supplementation with Lactobacillus rhamnosus, Lactobacillus fermentum, and Lactobacillus plantarum on anthropometric indices, appetite, and serum level of Nesfatin, Omentin-1, LPS, liver function markers, metabolic parameters, oxidative stress, and inflammatory biomarkers in obese individuals
    مقایسه تاثیر سه سویه پروبیوتیکی لاکتوباسیلوس رامنوسوس، لاکتوباسیلوس فرمنتوم و لاکتوباسیلوس پلانتاروم بومی بر شاخص های آنتروپومتری و سطح سرمی شاخص های متابولیک، استرس اکسیداتیو و التهابی در افراد چاق
    بررسی اثر مکمل یاری با پروبیوتیک های لاکتوباسیلوس رامنوسوس، لاکتوباسیلوس فرمنتوم و لاکتوباسیلوس پلانتاروم بومی بر شاخص های آنتروپومتریک، میزان اشتها و سطح سرمی نسفتین، امنتین-1، لیپوپلی ساکارید (LPS)، مارکرهای عملکرد کبدی، شاخص های متابولیک، استرس اکسیداتیو و التهابی در افراد چاق
    A clinical trial with control group and four parallel groups of 20 obese women, randomized through www.sealedenvelope.com
    A clinical trial with control group and four parallel groups of 25 obese people, randomized and triple blinded
    کارآزمایی بالینی دارای گروه کنترل، چهار گروه موازی 20تایی از زنان چاق، تصادفی شده از طریق سایت www.sealedenvelope.com
    کارآزمایی بالینی دارای گروه کنترل، چهار گروه موازی 25 تایی از افراد چاق، تصادفی شده و 3 سو کور
    People attending to the health centers in the city of Maragheh are invited to participate in this study. After having the consent to participate in this study, the address of Khajeh Nasir Nutrition Clinic will be given to them. All stages of research are done in that clinic. Patients who signed informed consent will be randomly divided into four groups. The first, second and third s will received Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus plantarum respectively and the control group will received placebo. The final outcome of the study will be assessed by a third party who is unaware of the study process. Also, the statistician will be unaware of the study process.
    Those who refer to Fardis Karaj laboratory are invited to participate in this study if they have the conditions to participate in the study and are willing to cooperate. People who signed the informed consent were randomly divided into the four mentioned groups. The supplements are prepared in the form of 1 gram powder sachets with similar packaging (for blinding) and with codes A to D, and people are requested to take 1 gram sachet daily before meals (mixed with water) for 2 Consume moon. At the beginning and end of the intervention, fasting blood sampling is done to determine the serum levels of the following biochemical variables in the amount of 6 cc.
    از مراجعه کنندگان به مراکز بهداشتی درمانی شهرستان مراغه دعوت به عمل می آید که در این مطالعه شرکت نمایند. پس از کسب رضایت جهت شرکت در این مطالعه، آدرس کلینیک تغذیه خواجه نصیر در اختیار ایشان قرار می گیرد. و تمامی مراحل تحقیق در آن کلینیک انجام می‌شود. بیمارانی که رضایت آگاهانه را امضا کردند به‌طور تصادفی به چهار گروه تقسیم می‌شوند. گروه اول لاکتوباسیلوس رامنوسوس، گروه دوم لاکتوباسیلوس فرمنتوم و گروه سوم لاکتوباسیلوس پلانتاروم و گروه کنترل دارونما دریافت کردند. نتیجه نهایی مطالعه توسط شخص ثالثی که از روند مطالعه بی اطلاع است ارزیابی می شود. همچنین آمارگیر از روند مطالعه بی اطلاع خواهد بود.
    از بین مراجعه کنندگان به آزمایشگاه فردیس کرج در صورت داشتن شرایط شرکت در مطالعه و نیز تمایل به همکاری دعوت به عمل می آید که در این مطالعه شرکت نمایند. افرادی که رضایت آگاهانه را امضا کردند به‌طور تصادفی به چهار گروه ذکر شده تقسیم می‌شوند. مکمل ها بصورت ساشه های پودری 1 گرمی با بسته بندی مشابه (جهت کورسازی) و دارای کدهای A تا D تهیه گردیده است و از افراد درخواست می گردد، روزانه 1 ساشه 1 گرمی را قبل از غذا (مخلوط با آب) و به مدت 2 ماه مصرف نمایند. در ابتدا و انتهای مداخله خونگیری ناشتا جهت تعیین سطوح سرمی متغیرهای بیوشیمیایی ذیل به میزان 6 سی سی انجام می گردد.
    Inclusion criteria included obese women in the range of body mass index (BMI ≤ 40), age group 18-60 years Exclusion criteria: in the last two months, having a special diet to treat obesity,
    Inclusion criteria: Volunteer Obese people in the range of body mass index( 30≤BMI ≤ 40) aged 18-60 years. Exclusion criteria: Allergy to probiotics; Having Diabetes, kidney disease, liver disease, and Thyroid disorders; Having a special diet to treat obesity in the last three months; Taking corticosteroids and/ or antibiotics; Regular Consumption of probiotics and/or nutritional supplements; Gastric surgery; pregnancy or lactation; Smoking and or drinking alcohol.
    معیار ورود شامل: زنان چاق در محدوده ی شاخص توده بدنی ( بین 30 تا 40)، گروه سنی 60-18 سال معیار خروج: در دو ماه اخیر داشتن رژیم خاص درمان چاقی
    معیار ورود شامل: افراد چاق داوطلب در محدوده ی شاخص توده بدنی (بین 30 تا 40)، گروه سنی 60-18 سال معیار خروج: حساسیت به پروبیوتیک های مصرف شده، ابتلا به دیابت، بیماری کلیه، کبد، اختلالات تیروئیدی، در سه ماه اخیر داشتن رژیم خاص درمان چاقی، مصرف کورتیکواستروئید ها و یا آنتی بیوتیک ها، مصرف منظم انواع پروبیوتیک و یا مکمل های تغذیه ای، جراحی معده، بارداری و شیردهی، مصرف سیگار و الکل
    group1:Probiotic supplement in powder sacs containing Lactobacillus fermentum 014 NIMBB (NCBI MT registration code 994667) isolated from the ridge (for 60 days) Group2:Lactobacillus rhamnosus NIMBB006 (NCBI MT registration code 995144) isolated from breast milk at a rate of 2 * 10 cfu(for 60 days) Group3: Lactobacillus plantarum isolated from camel milk (cfu 9 10 * 2 NCBI MT 012188)(for 60 days) Control group: Placebo with tasteless maltodextrin 100 for 60 days(for 60 days)
    Group1:Probiotic supplementation containing Lactobacillus fermentum (NCBI MT registration code 994667) Group2: Probiotic supplementation containing Lactobacillus rhamnosus (NCBI MT registration code 995144) Group3: Probiotic supplementation containing Lactobacillus plantarum (NCBI MT 012188) Control group: Placebo as pure maltodextrin
    افراد مورد مطالعه در 4 گروه قرار می گیرند. گروه 1:به مدت ۶۰ روز، مکمل پروبیوتیک به صورت ساشه های پودری حاوی باکتری های لاکتوباسیلوس فرمنتوم 014 NIMBB (NCBI MT کد ثبتی ۹۹۴۶۶۷ ) ایزوله شده از کومه گروه 2:به مدت ۶۰ روز، لاکتوباسیلوس رامنوسوس NIMBB۰۰۶ (NCBI MT کد ثبتی ۹۹۵۱۴۴ ) جداسازی شده ازشیر مادر به میزان cfu 9 10*2 گروه 3:به مدت ۶۰ روز، لاکتوباسیلوس پلانتاروم ایزوله شده از شیر شتر به میزان) cfu 9 10*2 کد ثبتی NCBI MT 012188 گروه کنترل:دارونما با مالتودکسترین ۱۰۰ بدون طعم، به مدت ۶۰ روز
    گروه 1: مصرف مکمل پروبیوتیک حاوی باکتری های لاکتوباسیلوس فرمنتوم (NCBI MT کد ثبتی ۹۹۴۶۶۷ ) گروه 2: مصرف مکمل پروبیوتیک حاوی لاکتوباسیلوس رامنوسوس (NCBI MT کد ثبتی ۹۹۵۱۴۴ ) گروه 3: مصرف مکمل پروبیوتیک حاوی لاکتوباسیلوس پلانتاروم (NCBI MT کد ثبتی 012188) گروه 4 : مصرف دارونما حاوی مالتودکسترین خالص
    Weight changes
    Changes of anthropometric measurements, appetite, serum levels of nesfatin, omentin, Lipopolysaccharide (LPS,) metabolic markers, oxidative stress, and inflammatory marker
    تغییرات وزن
    تغییرات تن سنجی (آنتروپومتری)، اشتها، تغییرات سرمی نسفتین، امنتین، لیپوپلی ساکارید (LPS) , مارکرهای متابولیک، وضعیت آنتی اکسیدانی و التهابی
  • General information

    PTO
    Female
    Both
    Not blinded
    Triple blinded
    1
    1
    1
    1
    1
    1
    empty
    3
    80
    100
    empty
    90
    empty
    2022-10-23, 1401/08/01
    empty
    2023-11-26, 1402/09/05
    empty
    Addition of some new parameters to the present project
    empty
    جهت افزودن برخی پارامترهای جدید به پروژه حاضر
    Probiotics in the treatment of obesity
    Effect of probiotics supplementation in the control of obesity
    پروبیوتک در درمان چاقی
    تاثیر مکمل یاری با سه سویه پروبیوتیکی بر کنترل چاقی
    The effect of Lactobacillus rhamnosus, Lactobacillus fermentum and Lactobacillus plantarum on anthropometric indices and circulating level of metabolic parameters, oxidative stress and inflammatory biomarkers in obese individuals
    The effect of supplementation with Lactobacillus rhamnosus, Lactobacillus fermentum, and Lactobacillus plantarum on anthropometric indices, appetite, and serum level of Nesfatin, Omentin-1, LPS, liver function markers, metabolic parameters, oxidative stress, and inflammatory biomarkers in obese individuals: a triple blinded RCT
    تاثیر سه سویه پروبیوتیکی لاکتوباسیلوس رامنوسوس، لاکتوباسیلوس فرمنتوم و لاکتوباسیلوس پلانتاروم بومی بر شاخص های آنتروپومتری و سطح سرمی شاخص های متابولیک، استرس اکسیداتیو و التهابی در افراد چاق: یک مطالعه کارآزمایی بالینی
    تاثیر مکمل یاری با پروبیوتیک های لاکتوباسیلوس رامنوسوس، لاکتوباسیلوس فرمنتوم و لاکتوباسیلوس پلانتاروم بومی بر شاخص های آنتروپومتریک، میزان اشتها و سطح سرمی نسفتین، امنتین-1، لیپوپلی ساکارید (LPS)، مارکرهای عملکرد کبدی، شاخص های متابولیک، استرس اکسیداتیو و التهابی در افراد چاق: یک کارآزمایی بالینی تصادفی سه سوکور
    Obese women in the range of body mass index( 30≤BMI ≤ 40)
    Age group of 18-60 years
    Obese people in the range of body mass index( 30≤BMI ≤ 40)
    Age group of 18-60 years
    Volunteers
    شامل زنان چاق در محدوده ی شاخص توده بدنی بین 30 تا 40
    گروه سنی 60-18 سال
    افراد چاق در محدوده ی شاخص توده بدنی بین 30 تا 40
    گروه سنی 60-18 سال
    داشتن تمایل به همکاری
    Allergy to probiotics
    Diabetes and chronic illness
    Having a special diet to treat obesity in the last two months
    Taking certain medications and corticosteroids
    Consumption of probiotics
    Gastric surgery
    Thyroid disorders
    Allergy to probiotics
    Having Diabetes, kidney disease, liver disease, Thyroid disorders
    Having a special diet to treat obesity in the last three months
    Taking corticosteroids and/ or antibiotics
    Regular Consumption of probiotics and/or nutritional supplements
    Gastric surgery
    Pregnancy. lactation
    Smoking and or drinking alcohol
    حساسیت به پروبیوتیک های مصرف شده
    دیابت و سایر بیماریهای مزمن
    در دو ماه اخیر داشتن رژیم خاص درمان چاقی
    مصرف داروهای خاص و کورتون
    مصرف انواع پروبیوتیک
    جراحی معده
    اختلالات تیروئیدی
    حساسیت به پروبیوتیک های مصرف شده
    ابتلا به دیابت، بیماری کلیه، کبد، اختلالات تیروئیدی،
    در سه ماه اخیر داشتن رژیم خاص درمان چاقی
    مصرف کورتیکواستروئید ها و یا آنتی بیوتیک ها
    مصرف منظم انواع پروبیوتیک و یا مکمل های تغذیه ای
    جراحی معده
    بارداری و شیردهی
    مصرف سیگار و الکل
    After randomization, intervention groups 1 to 3 received powdered sachets containing isolated probiotics Lactobacillus rhamnus, fermentum, and plantarum, respectively, and group 4 received sachets containing maltodextrin as 1 sachet daily before the meal for 60 days. Sachets related to each group were prepared in similar and same-colored packages and provided to them monthly. For further blinding, the packaging of supplements and their coding (A-D) were done by someone outside of the project and other than the main researchers. The patient, doctors, statistical analyst, and the main researcher did not know those codes. After completing the study, the codes will be decoded.
    بعد از تصادفی سازی، گروه مداخله 1 تا 3 به ترتیب ساشه های پودری حاوی پروبیوتیک های ایزوله شده لاکتوباسیلوس رامنسوس، فرمنتوم و پلانتاروم و گروه 4 ساشه های حاوی مالتودکسترین را به صورت روزانه 1 ساشه قبل غذا به مدت60 روز دریافت کردند. ساشه های مربوط به هر گروه در بسته های مشابه و همرنگ تهیه و بصورت ماهانه در اختیار آنها قرار گرفت. لازم به ذکر است به منظور کورسازی بیشتر بسته بندی مکمل ها و کد گذاری آنها (A-D) توسط فردی خارج از طرح و غیر از محققین اصلی انجام گرفت. تا زمان حصول نتایج مطالعه، بیمار، پزشکان، آنالیزگر آماری و محقق از کدهای اختصاصی شده اطلاعی نداشتند و بعد اتمام مطالعه و آنالیز آماری کدها رمزگشایی خواهد شد.
  • Ethics committees

    #1
    empty
    2024-07-08, 1403/04/18
    empty
    IR.TBZMED.REC.1403.264
    #2
    empty
    2024-08-05, 1403/05/15
    empty
    IR.TBZMED.REC.1403.361
    #3
    empty
    2024-08-05, 1403/05/15
    empty
    IR.TBZMED.REC.1403.362
  • Primary outcomes

    #1
    Anthropometric indicators (height and weight, waist circumference and hip circumference)
    Anthropometric indicators (height, weight, BMI, waist circumference)
    شاخص های تن سنجی(قد و وزن، دور کمر و دور باسن)
    شاخص های تن سنجی(قد و وزن، BMI، دور کمر )
    The first day and two months later
    At first and end of two months intervention
    روز اول و دو ماه بعد از مداخله
    ابتدا و انتهای 2 ماه مداخله
    Meter
    Weight scale, Meter
    متر
    ترازو و متر نواری
    #2
    empty
    Novel anthropometric indexes e.g., ABSI, BRI)
    empty
    شاخص های تن سنجی جدید شامل شاخص شکل بدن (ABSI)، شاخص گردی بدن (BRI)
    empty
    Weight scale, Meter
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    Weight scale, Meter, related formula
    empty
    ترازو و متر نواری و استفاده از فرمول مربوطه
    #3
    empty
    appetite
    empty
    اشتها
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    questionnaire
    empty
    پرسشنامه
    #4
    empty
    Serum level of Nesfatin
    empty
    سطح سرمی نسفتین
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    Elisa kit
    empty
    بروش الایزا با استفاده از کیت مربوطه
    #5
    empty
    serum level of Omentin-1
    empty
    سطح سرمی امنتین-1
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    Elisa kit
    empty
    بروش الایزا با استفاده از کیت مربوطه
    #6
    empty
    serum level of LPS
    empty
    سطح سرمی لیپوپلی ساکارید (LPS)
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    Elisa kit
    empty
    بروش الایزا با استفاده از کیت مربوطه
    #7
    empty
    Liver function test (ALT, AST, ALP)
    empty
    مارکرهای عملکرد کبدی (آلانین ترانس آمیناز، آسپارتات ترانس آمیناز و آلکالین ترانسفراز)
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    Auto-analyzer based on the principle of photometry
    empty
    اتوآنالایزر بر اساس روش رنگ سنجی
    #8
    empty
    FBS
    empty
    قند خون ناشتا
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    Auto-analyzer based on the principle of photometry
    empty
    اتوآنالایزر بر اساس روش رنگ سنجی
    #9
    empty
    serum Insulin
    empty
    سطح سرمی انسولین
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    Elisa kit
    empty
    بروش الایزا با استفاده از کیت مربوطه
    #10
    empty
    lipid profile ( TC, TG, LDL.C, HDL.C)
    empty
    پروفایل لیپیدی (توتال کلسترول و تری گلیسرید و LDL.C , HDL.C)
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    Auto-analyzer based on the principle of photometry
    empty
    اتوآنالایزر بر اساس روش رنگ سنجی
    #11
    empty
    MDA
    empty
    سطح سرمی مالون دی الدئید
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    Spectrophotometer
    empty
    اسپکتروفوتومتر
    #12
    empty
    TAC
    empty
    ظرفیت توتال آنتی اکسیدان
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    Elisa kit
    empty
    بروش الایزا با استفاده از کیت مربوطه
    #13
    empty
    TOC
    empty
    ظرفیت توتال اکسیدانت
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    Elisa kit
    empty
    بروش الایزا با استفاده از کیت مربوطه
    #14
    empty
    CRP
    empty
    سطح سرمی پروتئین واکنشی (CRP
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    photometry
    empty
    رنگ سنجی
    #15
    empty
    IL-6
    empty
    سطح سرمی اینترلوکین 6
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    ELISA KIT
    empty
    الایزا
    #16
    empty
    IL-1 B
    empty
    سطح سرمی اینترلوکین 1 بتا
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    ELISA KIT
    empty
    الایزا
    #17
    empty
    TNF alfa
    empty
    سطح سرمی فاکتور نکروزه کننده تومور
    empty
    At first and end of two months intervention
    empty
    ابتدا و انتهای 2 ماه مداخله
    empty
    ELISA KIT
    empty
    الایزا
  • Secondary outcomes

    #1
    Serum level Total body antioxidant capacity (serum TAC level)
    Blood urea nitrogen
    سطح سرمی ظرفیت کلی آنتی اکسیدانی بدن(سطح سرمی TAC)
    میزان ازت اوره خون (BUN)
    The first day and two months later
    At first and end of two months intervention
    روز اول و دو ماه بعد
    ابتدا و انتهای 2 ماه مداخله
    Spectrophotometry and enzyme kit
    autoanalyzer
    اسپکتروفوتومتری و کیت آنزیمی
    اتوآنالایزر
    #2
    Reactive aldehyde active compound (serum MDA level)
    CREATININ
    ترکیب فعال آلدئیدی واکنش پذیر (سطح سرمی MDA)
    سطح سرمی کراتینین
    The first day and two months later
    At first and end of two months intervention
    روز اول و دو ماه بعد
    ابتدا و انتهای 2 ماه مداخله
    Flowmetry
    autoanalyzer
    فلومتری
    اتوآنالایزر
    #3
    Serum level of IL-6
    empty
    سطح سرمی IL-6
    empty
    The first day and two months later
    empty
    روز اول و دو ماه بعد
    empty
    Eliza
    empty
    الایزا
    empty
    #4
    Fasting blood sugar
    empty
    قند خون ناشتا
    empty
    The first day and two months later
    empty
    روز اول و دو ماه بعد
    empty
    BT autoanalyzer device ( Biotecnica BT)
    empty
    دستگاه اتوآنالایزر BT
    empty
  • Intervention groups

    #1
    گروه مداخله:(گروه 1) به مدت ۶۰ روز مکمل پروبیوتیک به صورت ساشه های پودری حاوی باکتری های لاکتوباسیلوس فرمنتوم 014 NIMBB (NCBI MT registration code 994667) ایزوله شده از کومه
    گروه مداخله: (گروه 1) به مدت ۶۰ روز مکمل پروبیوتیک به صورت ساشه های پودری حاوی باکتری های لاکتوباسیلوس فرمنتوم 014 NIMBB (NCBI MT registration code 994667) ایزوله شده از کومه
    #2
    گروه مداخله(گروه 2) به مدت ۶۰ روز لاکتوباسیلوس رامنوسوس NIMBB۰۰۶ (NCBI MT کد ثبتی ۹۹۵۱۴۴ ) جداسازی شده ازشیر مادر به میزان cfu 9 10*2
    گروه مداخله (گروه 2) به مدت ۶۰ روز لاکتوباسیلوس رامنوسوس NIMBB۰۰۶ (NCBI MT کد ثبتی ۹۹۵۱۴۴ ) جداسازی شده ازشیر مادر به میزان cfu 9 10*2
    #3
    گروه مداخله(گروه 3) به مدت ۶۰ روز لاکتوباسیلوس پلانتاروم ایزوله شده از شیر شتر به میزان) cfu 9 10*2 کد ثبتی NCBI MT 012188
    گروه مداخله (گروه 3) به مدت ۶۰ روز لاکتوباسیلوس پلانتاروم ایزوله شده از شیر شتر به میزان) cfu 9 10*2 کد ثبتی NCBI MT 012188
  • Sponsors / Funding sources

    #1

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Mohammad Nourisepehr
    Full name of responsible person - Persian: محمدنوری سپهر
    Street address - English: Vice Chancellor for Research; No.20; Saffarian alley; 45 Metri Golshahr street
    Street address - Persian: خیابان 45 متری گلشهر، کوچه صفاریان، پلاک 20، معاونت تحقیقات و فناوری
    City - English: Tehran
    City - Persian: تهران
    Province: Tehran
    Country: Iran (Islamic Republic of)
    Postal code: 3198764653
    Phone: +98 26 3464 3705
    Fax:
    Email: Research@abzums.ac.ir
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Mohammad Nourisepehr
    Full name of responsible person - Persian: محمدنوری سپهر
    Street address - English: Vice Chancellor for Research; No.20; Saffarian alley; 45 Metri Golshahr street
    Street address - Persian: خیابان 45 متری گلشهر، کوچه صفاریان، پلاک 20، معاونت تحقیقات و فناوری
    City - English: تبریز
    City - Persian: تبریز
    Province: Alborz
    Country: Iran (Islamic Republic of)
    Postal code: 3198764653
    Phone: +98 26 3464 3705
    Fax:
    Email: Research@abzums.ac.ir
    Web page address:
    100
    30
    Karaj university of medical sciences
    Karaj University of Medical Sciences
    #2

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Parviz Shahabi
    Full name of responsible person - Persian: پرویز شهابی
    Street address - English: University Street, Vice Chancellor of Research of Tabriz University of Medical Sciences
    Street address - Persian: خیابان دانشگاه، معاونت پژوهشی دانشگاه علوم پزشکی تبریز
    City - English: Tabriz
    City - Persian: تبریز
    Province: East Azarbaijan
    Country: Iran (Islamic Republic of)
    Postal code: 5166614711
    Phone: +98 41 3334 4280
    Fax:
    Email: parvizshahabi@gmail.com
    Web page address:
    empty
    Yes
    empty
    70
    empty
    Public
    empty
    Domestic
    empty
    Academic
    empty
    Tabriz University of Medical Sciences
    empty
    دانشگاه علوم پزشکی تبریز
  • Person responsible for general inquiries


    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Jamileh Ghalami
    Full name of responsible person - Persian: جمیله قلمی
    Position - English: Employee
    Position - Persian: کارمند
    Latest degree: phd
    Area of specialty/work: 69
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: No.13.West. Ave., Vahdat Town
    Street address - Persian: شهرک وحدت 13 غربی پلاک 13 واحد6
    City - English: Karaj
    City - Persian: کرج
    Province: Alborz
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code: 3149779453
    Phone: +98 26 3664 8761
    Mobile: +98 914 306 6305
    Fax:
    Email: j.ghalami@abzums.ac.ir
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Jamileh Ghalami
    Full name of responsible person - Persian: جمیله قلمی
    Position - English: Employee
    Position - Persian: کارمند
    Latest degree: phd
    Area of specialty/work: 69
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: Unit 6, No.13, 13 West Ave., Vahdat Town
    Street address - Persian: شهرک وحدت، 13 غربی، پلاک 13، واحد 6
    City - English: Karaj
    City - Persian: کرج
    Province: Alborz
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code: 3149779453
    Phone: +98 26 3664 8761
    Mobile: +98 914 306 6305
    Fax:
    Email: s_ghalami@yahoo.com
    Web page address:
  • Person responsible for scientific inquiries


    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Jamileh Ghalami
    Full name of responsible person - Persian: جمیله قلمی
    Position - English: Employee
    Position - Persian: کارمند
    Latest degree: phd
    Area of specialty/work: 69
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: No.13.West, Ave, Vahdat Town
    Street address - Persian: شهرک وحدت، 13 غربی ، پلاک 13، واحد6
    City - English: Karaj
    City - Persian: کرج
    Province: Alborz
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code: 3149779453
    Phone: +98 26 3664 8761
    Mobile: +98 914 306 6305
    Fax:
    Email: j.ghalami@abzums.ac.ir
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Vahideh Ebrahimzadeh Attari
    Full name of responsible person - Persian: وحیده ابراهیم زاده عطاری
    Position - English: Academic staff
    Position - Persian: عضو هیئت علمی
    Latest degree: phd
    Area of specialty/work: 34
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: Tabriz university of Medical Sciences, Faculty of nutrition, Attar Neyshaboori avenue,
    Street address - Persian: خیابان عطار نیشابوری، دانشکده تغذیه و علوم غذایی، دانشگاه علوم پزشکی تبریز
    City - English: Tabriz
    City - Persian: تبریز
    Province: East Azarbaijan
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code: 516665931
    Phone: +98 41 3335 7581
    Mobile: +98 914 300 9074
    Fax:
    Email: ebrahimzadeh.va@gmail.com
    Web page address:
  • Person responsible for updating data


    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Jamileh Ghalami
    Full name of responsible person - Persian: جمیله قلمی
    Position - English: Employee
    Position - Persian: کارمند
    Latest degree: phd
    Area of specialty/work: 69
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: No.13.West, Ave,Vahdat Town
    Street address - Persian: شهرک وحدت، 13 غربی، پلاک 13، واحد6
    City - English: Karaj
    City - Persian: کرج
    Province: Alborz
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code: 3149779453
    Phone: +98 26 3664 8761
    Mobile: +98 914 306 6305
    Fax:
    Email: j.ghalami@abzums.ac.ir
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Vahideh Ebrahimzadeh Attari
    Full name of responsible person - Persian: وحیده ابراهیم زاده عطاری
    Position - English: academic staff
    Position - Persian: عضو هیئت علمی
    Latest degree: phd
    Area of specialty/work: 34
    Area of specialty/work title - English:
    Area of specialty/work title - Persian:
    Street address - English: Tabriz university of Medical Sciences, Faculty of nutrition, Attar Neyshaboori avenue,
    Street address - Persian: خیابان عطار نیشابوری، دانشکده تغذیه و علوم غذایی، دانشگاه علوم پزشکی تبریز
    City - English: Tabriz
    City - Persian: تبریز
    Province: East Azarbaijan
    Province - English:
    Province - Persian:
    contact.provinces_available: 1
    Country: Iran (Islamic Republic of)
    Postal code: 516665931
    Phone: +98 41 3335 7581
    Mobile: +98 914 300 9074
    Fax:
    Email: ebrahimzadeh.va@gmail.com
    Web page address:
  • Sharing plan

    undecided
    yes
    undecided
    yes
    undecided
    yes
    undecided
    yes
    undecided
    yes
    undecided
    no
    undecided
    no
    It is not yet known if there will be a plan to make this available
    empty
    هنوز تصمیم گرفته نشده است
    empty
    empty
    results publication
    empty
    انتشار نتایج
    empty
    After publishing the articles
    empty
    بعد اتمام و انتشار مقالات طرح
    empty
    Researchers
    empty
    محققین دانشگاه
    empty
    with permission of the responsible members of the project
    empty
    با کسب اجازه از مسئول پاسخگویی طرح
    empty
    Dr. Vahideh Ebrahimzadeh Attari, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, ebrahimzadeh.va@gmail.com
    empty
    دکتر وحیده ابراهیم زاده عطاری- دانشکده تغذیه و علوم غذایی، دانشگاه علوم پزشکی تبریز ebrahimzadeh.va@gmail.com
    empty
    please send an Email to: ebrahimzadeh.va@gmail.com
    empty
    دریافت کننده می تواند از طریق ایمیل تقاضای خود را به فرد مسئول مطالعه ارسال نماید.

Protocol summary

Study aim
The assessment of the effect of supplementation with Lactobacillus rhamnosus, Lactobacillus fermentum, and Lactobacillus plantarum on anthropometric indices, appetite, and serum level of Nesfatin, Omentin-1, LPS, liver function markers, metabolic parameters, oxidative stress, and inflammatory biomarkers in obese individuals
Design
A clinical trial with control group and four parallel groups of 25 obese people, randomized and triple blinded
Settings and conduct
Those who refer to Fardis Karaj laboratory are invited to participate in this study if they have the conditions to participate in the study and are willing to cooperate. People who signed the informed consent were randomly divided into the four mentioned groups. The supplements are prepared in the form of 1 gram powder sachets with similar packaging (for blinding) and with codes A to D, and people are requested to take 1 gram sachet daily before meals (mixed with water) for 2 Consume moon. At the beginning and end of the intervention, fasting blood sampling is done to determine the serum levels of the following biochemical variables in the amount of 6 cc.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Volunteer Obese people in the range of body mass index( 30≤BMI ≤ 40) aged 18-60 years. Exclusion criteria: Allergy to probiotics; Having Diabetes, kidney disease, liver disease, and Thyroid disorders; Having a special diet to treat obesity in the last three months; Taking corticosteroids and/ or antibiotics; Regular Consumption of probiotics and/or nutritional supplements; Gastric surgery; pregnancy or lactation; Smoking and or drinking alcohol.
Intervention groups
Group1:Probiotic supplementation containing Lactobacillus fermentum (NCBI MT registration code 994667) Group2: Probiotic supplementation containing Lactobacillus rhamnosus (NCBI MT registration code 995144) Group3: Probiotic supplementation containing Lactobacillus plantarum (NCBI MT 012188) Control group: Placebo as pure maltodextrin
Main outcome variables
Changes of anthropometric measurements, appetite, serum levels of nesfatin, omentin, Lipopolysaccharide (LPS,) metabolic markers, oxidative stress, and inflammatory marker

General information

Reason for update
Addition of some new parameters to the present project
Acronym
IRCT registration information
IRCT registration number: IRCT20220608055106N1
Registration date: 2022-07-03, 1401/04/12
Registration timing: prospective

Last update: 2024-08-21, 1403/05/31
Update count: 1
Registration date
2022-07-03, 1401/04/12
Registrant information
Name
Jamileh Ghalami
Name of organization / entity
The university of Alborz
Country
Iran (Islamic Republic of)
Phone
+98 26 3664 8761
Email address
s_ghalami@yahoo.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-07-23, 1401/05/01
Expected recruitment end date
2023-08-01, 1402/05/10
Actual recruitment start date
2022-10-23, 1401/08/01
Actual recruitment end date
2023-11-26, 1402/09/05
Trial completion date
empty
Scientific title
The effect of supplementation with Lactobacillus rhamnosus, Lactobacillus fermentum, and Lactobacillus plantarum on anthropometric indices, appetite, and serum level of Nesfatin, Omentin-1, LPS, liver function markers, metabolic parameters, oxidative stress, and inflammatory biomarkers in obese individuals: a triple blinded RCT
Public title
Effect of probiotics supplementation in the control of obesity
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Obese people in the range of body mass index( 30≤BMI ≤ 40) Age group of 18-60 years Volunteers
Exclusion criteria:
Allergy to probiotics Having Diabetes, kidney disease, liver disease, Thyroid disorders Having a special diet to treat obesity in the last three months Taking corticosteroids and/ or antibiotics Regular Consumption of probiotics and/or nutritional supplements Gastric surgery Pregnancy. lactation Smoking and or drinking alcohol
Age
From 18 years old to 60 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Care provider
  • Investigator
  • Outcome assessor
  • Data analyser
  • Data and Safety Monitoring Board
Sample size
Target sample size: 100
Actual sample size reached: 90
Randomization (investigator's opinion)
Randomized
Randomization description
Block randomization method with non-matched block size will be studied. For this purpose, a list of the order of allocation of samples by the second (non-original) researcher and using the software provided on the website https://www.sealedenvelope.com. Prepared and the size of the blocks will be two, four and six.
Blinding (investigator's opinion)
Triple blinded
Blinding description
After randomization, intervention groups 1 to 3 received powdered sachets containing isolated probiotics Lactobacillus rhamnus, fermentum, and plantarum, respectively, and group 4 received sachets containing maltodextrin as 1 sachet daily before the meal for 60 days. Sachets related to each group were prepared in similar and same-colored packages and provided to them monthly. For further blinding, the packaging of supplements and their coding (A-D) were done by someone outside of the project and other than the main researchers. The patient, doctors, statistical analyst, and the main researcher did not know those codes. After completing the study, the codes will be decoded.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Alborz University of Medical Sciences
Street address
Ethics committee unit,Vice Chancellor for Research, No.20, Saffarian alley, 45 Metri Golshahr street
City
Tehran
Province
Tehran
Postal code
3149779453
Approval date
2022-05-21, 1401/02/31
Ethics committee reference number
IR.ABZUMS.REC.1401.054

2

Ethics committee
Name of ethics committee
Ethics committee of Tabriz University of Medical Sciences
Street address
Golgasht, Tabriz University of Medical Sciences
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Approval date
2024-07-08, 1403/04/18
Ethics committee reference number
IR.TBZMED.REC.1403.264

3

Ethics committee
Name of ethics committee
Ethics committee of Tabriz University of Medical Sciences
Street address
Golgasht, Tabriz University of Medical Sciences
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Approval date
2024-08-05, 1403/05/15
Ethics committee reference number
IR.TBZMED.REC.1403.361

4

Ethics committee
Name of ethics committee
Ethics committee of Tabriz University of Medical Sciences
Street address
Golgasht, Tabriz University of Medical Sciences
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Approval date
2024-08-05, 1403/05/15
Ethics committee reference number
IR.TBZMED.REC.1403.362

Health conditions studied

1

Description of health condition studied
Overweight and obesity
ICD-10 code
E66
ICD-10 code description
Overweight and obesity

Primary outcomes

1

Description
Anthropometric indicators (height, weight, BMI, waist circumference)
Timepoint
At first and end of two months intervention
Method of measurement
Weight scale, Meter

2

Description
Novel anthropometric indexes e.g., ABSI, BRI)
Timepoint
Weight scale, Meter
Method of measurement
Weight scale, Meter, related formula

3

Description
appetite
Timepoint
At first and end of two months intervention
Method of measurement
questionnaire

4

Description
Serum level of Nesfatin
Timepoint
At first and end of two months intervention
Method of measurement
Elisa kit

5

Description
serum level of Omentin-1
Timepoint
At first and end of two months intervention
Method of measurement
Elisa kit

6

Description
serum level of LPS
Timepoint
At first and end of two months intervention
Method of measurement
Elisa kit

7

Description
Liver function test (ALT, AST, ALP)
Timepoint
At first and end of two months intervention
Method of measurement
Auto-analyzer based on the principle of photometry

8

Description
FBS
Timepoint
At first and end of two months intervention
Method of measurement
Auto-analyzer based on the principle of photometry

9

Description
serum Insulin
Timepoint
At first and end of two months intervention
Method of measurement
Elisa kit

10

Description
lipid profile ( TC, TG, LDL.C, HDL.C)
Timepoint
At first and end of two months intervention
Method of measurement
Auto-analyzer based on the principle of photometry

11

Description
MDA
Timepoint
At first and end of two months intervention
Method of measurement
Spectrophotometer

12

Description
TAC
Timepoint
At first and end of two months intervention
Method of measurement
Elisa kit

13

Description
TOC
Timepoint
At first and end of two months intervention
Method of measurement
Elisa kit

14

Description
CRP
Timepoint
At first and end of two months intervention
Method of measurement
photometry

15

Description
IL-6
Timepoint
At first and end of two months intervention
Method of measurement
ELISA KIT

16

Description
IL-1 B
Timepoint
At first and end of two months intervention
Method of measurement
ELISA KIT

17

Description
TNF alfa
Timepoint
At first and end of two months intervention
Method of measurement
ELISA KIT

Secondary outcomes

1

Description
Blood urea nitrogen
Timepoint
At first and end of two months intervention
Method of measurement
autoanalyzer

2

Description
CREATININ
Timepoint
At first and end of two months intervention
Method of measurement
autoanalyzer

Intervention groups

1

Description
Intervention group: (group1) Probiotic supplement in powder sacs containing Lactobacillus fermentum 014 NIMBB (NCBI MT registration code 994667) isolated from the ridge (for 60 days)
Category
Treatment - Drugs

2

Description
Intervention group:(Group2) Lactobacillus rhamnosus NIMBB006 (NCBI MT registration code 995144) isolated from breast milk at a rate of 2 * 10 cfu (for 60 days)
Category
Treatment - Drugs

3

Description
Intervention group ( Group3) Lactobacillus plantarum isolated from camel milk (cfu 9 10 * 2 NCBI MT 012188)(for 60 days)
Category
Treatment - Drugs

4

Description
Control group: Placebo with tasteless maltodextrin 100 for 60 days(for 60 days)
Category
Placebo

Recruitment centers

1

Recruitment center
Name of recruitment center
Khajeh Nasir al-Din Nutrition Clinic
Full name of responsible person
Jamileh Ghalami
Street address
Shahid Dastgheib St, Maragheh, East Azarbaijan,
City
Maragheh
Province
East Azarbaijan
Postal code
5515878151
Phone
+98 41 3723 1618
Email
s_ghalami@yahoo.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Karaj University of Medical Sciences
Full name of responsible person
Mohammad Nourisepehr
Street address
Vice Chancellor for Research; No.20; Saffarian alley; 45 Metri Golshahr street
City
تبریز
Province
Alborz
Postal code
3198764653
Phone
+98 26 3464 3705
Email
Research@abzums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
No
Title of funding source
Karaj University of Medical Sciences
Proportion provided by this source
30
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

2

Sponsor
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Parviz Shahabi
Street address
University Street, Vice Chancellor of Research of Tabriz University of Medical Sciences
City
Tabriz
Province
East Azarbaijan
Postal code
5166614711
Phone
+98 41 3334 4280
Fax
Email
parvizshahabi@gmail.com
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tabriz University of Medical Sciences
Proportion provided by this source
70
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Karaj University of Medical Sciences
Full name of responsible person
Jamileh Ghalami
Position
Employee
Latest degree
Ph.D.
Other areas of specialty/work
Physiology
Street address
Unit 6, No.13, 13 West Ave., Vahdat Town
City
Karaj
Province
Alborz
Postal code
3149779453
Phone
+98 26 3664 8761
Fax
Email
s_ghalami@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Vahideh Ebrahimzadeh Attari
Position
Academic staff
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Tabriz university of Medical Sciences, Faculty of nutrition, Attar Neyshaboori avenue,
City
Tabriz
Province
East Azarbaijan
Postal code
516665931
Phone
+98 41 3335 7581
Fax
Email
ebrahimzadeh.va@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Vahideh Ebrahimzadeh Attari
Position
academic staff
Latest degree
Ph.D.
Other areas of specialty/work
Nutrition
Street address
Tabriz university of Medical Sciences, Faculty of nutrition, Attar Neyshaboori avenue,
City
Tabriz
Province
East Azarbaijan
Postal code
516665931
Phone
+98 41 3335 7581
Fax
Email
ebrahimzadeh.va@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Title and more details about the data/document
results publication
When the data will become available and for how long
After publishing the articles
To whom data/document is available
Researchers
Under which criteria data/document could be used
with permission of the responsible members of the project
From where data/document is obtainable
Dr. Vahideh Ebrahimzadeh Attari, Faculty of Nutrition and Food Sciences, Tabriz University of Medical Sciences, ebrahimzadeh.va@gmail.com
What processes are involved for a request to access data/document
please send an Email to: ebrahimzadeh.va@gmail.com
Comments
Loading...